HCPCS Level IIdrugActive
J0714
Ceftazidime and avibactam
BETOS: O1E
Effective: 2016-01-01
Description
Injection, ceftazidime and avibactam, 0.5 g/0.125 g
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Avycaz
Manufacturer
Allergan, Inc.
HCPCS Dosage
.625 GM
Billing Units
4.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.